Skip To Main Content
Jeanne Lenzer on Muck Rack

Jeanne Lenzer

Verified
New York
As seen in: The BMJ, National Institutes of Health, The New York Times, The Washington Post, New York Post, The Atlantic, Scientific American, Slate, Smithsonian Magazine, Men's Health, AARP and

Get in touch with Jeanne

Contact Jeanne, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Jeanne Lenzer’s Biography

Read Full Bio →

I am an independent medical investigative journalist and former Knight Science Journalism fellow. My book, The Danger Within Us: America's Untested, Unregulated Medical Device Industry and One Man's Battle to Survive It, takes readers through the FDA approval process, medical research illusions and was reviewed by Jerome Groopman and others.

I have been a regular contributor to the international medical journal, The BMJ, and my articles, reviews, and commentary have appeared in The New York …

Jeanne Lenzer’s Journalist Portfolio

Can Cancer Ever Be Ignored?

Can Cancer Ever Be Ignored?

So what should a man do when his doctor suggests a routine PSA test? Shannon Brownlee and i plunge into the a…

View article →
When the Cure Is the Cause: The Case of the Green Hairy Tongue

When the Cure Is the Cause: The Case of the Green Hairy Tongue

Keiko Yamaguchi's troubles began with diarrhea. After a few weeks, her toes went numb. The numbness and weakn…

View article →

Articles

The Profit Motive Behind New Alzheimer’s Treatments

|
By Jeanne Lenzer Verified
| Jacobin Verified
When Barbara Feuerstein, seventy-two, saw a Facebook ad offering a free blood test for Alzheimer’s disease, she jumped at the opportunity. The ad, placed by a research center, offered the test, recently cleared by the Food and Drug Administration (FDA), as part of a drug study to prevent the disease. “I figured it must be safe if it was FDA approved,” said Feuerstein.
Open in Who Shared Issue with article?

The Campaign To Turn Healthy People Into Alzheimer’s Patients

|
By Jeanne Lenzer Verified
| The Lever Verified
When Barbara Feuerstein, 72, saw a Facebook ad offering a free blood test for Alzheimer’s disease, she jumped at the opportunity. The ad, placed by a research center, offered the test, recently cleared by the Food and Drug Administration, as part of a drug study to prevent the disease. “I figured it must be safe if it was FDA approved,” said Feuerstein.
Open in Who Shared Issue with article?

Should You Take The Alzheimer’s Blood Test?

|
By Jeanne Lenzer Verified
| The Lever Verified
Registered readers of The Lever get access to a limited number of free articles every month, breaking news alerts, and our Lever Daily newsletter. Great! Check your inbox and click the link. Sorry, something went wrong. Please try again. Already have an account? Sign in
Open in Who Shared Issue with article?
See all 109 licensed articles (110 Total)